ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "depression"

  • Abstract Number: 2485 • ACR Convergence 2023

    Comparative Risk of Serious Psychiatric Events with Belimumab versus Oral Immunosuppressant Use in Patients with Systemic Lupus Erythematosus

    April Jorge1, Baijun Zhou1, Yuqing Zhang2 and Hyon K. Choi3, 1Massachusetts General Hospital, Boston, MA, 2Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Boston, MA, 3Massachusetts General Hospital and Harvard Medical School, Lexington, MA

    Background/Purpose: In randomized placebo-controlled trials, including the phase 4 Belimumab Assessment of Safety in SLE study, belimumab use was associated with a higher incidence of…
  • Abstract Number: 1640 • ACR Convergence 2023

    Psoriatic Disease Associated with Neuroconnectivity Alterations in the Default Mode Network

    Rebecca Haberman1, Sydney Catron1, Yu Veronica Sui1, Sarah Moussavi1, Soumya Reddy2, Eileen Lydon3, Andrea Neimann1, Alexis R Ogdie4, Mariana Lazar1 and Jose Scher5, 1NYU Grossman School of Medicine, New York, NY, 2NYU School of Medicine, New York, NY, 3New York University, New York, NY, 4University of Pennsylvania, Philadelphia, PA, 5New York University School of Medicine, New York, NY

    Background/Purpose: Despite significant advances in psoriatic disease (PsD) therapeutics, treatment response remains suboptimal. Even in patients with psoriatic arthritis (PSA) that achieve seemingly controlled inflammation,…
  • Abstract Number: 1828 • ACR Convergence 2023

    Positive Screening for Fibromyalgia or Depression on Validated MDHAQ Indices Is Seen in 56-71% of Rheumatoid Arthritis Patients with High DAS28 or CDAI, 40-47% with Moderate, 2-42% with Low, and 0-21% with DAS28 or CDAI Remission

    Theodore Pincus1, Rahel Hunter1 and Nicholas Rodwell2, 1Rush University Medical Center, Chicago, IL, 2Liverpool Hospital, Liverpool, Australia

    Background/Purpose: DAS28 (disease activity score 28) and CDAI (clinical disease activity index) are prominent indices to assess patients with rheumatoid arthritis (RA) quantitatively, for which…
  • Abstract Number: 1837 • ACR Convergence 2023

    Depression and Suicide Attempt in Systemic Lupus Erythematosus with and Without Fibromyalgia

    Irakli Tskhakaia1, Pushti Khandwala1 and Irene Tan2, 1Albert Einstein Medical Center Philadelphia, Philadelphia, PA, 2Einstein Medical Center Philadelphia, Bala Cynwyd, PA

    Background/Purpose: Suicide and depression represent a high burden of morbidity and mortality worldwide. It is well known that fibromyalgia (FM) is associated with mood and…
  • Abstract Number: 0121 • ACR Convergence 2023

    High Prevalence of Mental Health Disorders Among Patients with Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Jeong Yee1, Candace Feldman1, Emily G. Oakes1, Elizabeth Karlson1, Jack Ellrodt1, Laura Kubzansky2, Karestan Koenen2 and Karen Costenbader3, 1Brigham and Women's Hospital, Boston, MA, 2Harvard T.H. Chan School of Public Health, Boston, MA, 3Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) are complex autoimmune diseases associated with pain and decreased quality of life. Mental health conditions related…
  • Abstract Number: 1838 • ACR Convergence 2023

    The Burden of Dysautonomia in Patients Suffering from Pathologies Associated with Generalized Joint Hypermobility

    Alizée Perrein1, Fabien Pontille1, Paul Decker2, david Attali3, Thomas Moulinet4 and Roland Jaussaud5, 1Département de Médecine interne et immunologie clinique, Université de Lorraine / CHRU de Nancy, Vandoeuvre-les-Nancy, France, 2Nancy hospital, France, Nancy, France, 3Université Paris Cité, Laboratoire Psychopathologie et Processus de Santé, Boulogne-Billancourt, France, 4Department of Internal Medicine, Centre hospitalier universitaire de Nancy, Nancy, France, 5Département de Médecine interne et immunologie clinique, Université de Lorraine / CHRU de Nancy, Vandoeuvre Les Nancy, France

    Background/Purpose: Hypermobility spectrum disorders (HSD) and hypermobile Ehlers Danlos syndrome (hEDS) are among the conditions associated with generalized joint hypermobility (GJH). Alongside myofascial and skeletal…
  • Abstract Number: 0150 • ACR Convergence 2023

    Self-reported Levels of Physical Activity and the Association to Pain, Fatigue, Anxiety and Depression Among Patients with Idiopathic Inflammatory Myopathies

    Kristofer Andreasson1, Fabricio Espinosa-Ortega2, Heléne Sandlund3 and Helene Alexanderson4, 1Karolinska Institutet & Karolinska University Hospital, Stockholm, Sweden, 2Division of Rheumatology, Department of Medicine, Karolinska Institutet; Department of Gastroenterology, Dermatotology, Rhematology, Karolinska Universitetssjukhuset, Stockholm, Sweden, 3Karolinska University Hospital, Stockholm, Sweden, 4Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: Patients with inflammatory diseases such as rheumatoid arthritis exhibit reduced levels of physical activity (PA) compared to the normative population and suffer from anxiety…
  • Abstract Number: 1857 • ACR Convergence 2023

    More Than 50% of Rheumatoid Arthritis (RA) Patients with High or Moderate CDAI (clinical Disease Activity Index) Screen Positive on MDHAQ (multidimensional Health Assessment Questionnaire) Indices for FAST4 (fibromyalgia Assessment Screening Tool) And/or MDS2 (MDHAQ Depression Screen)

    Juan Schmukler and Theodore Pincus, Rush University Medical Center, Chicago, IL

    Background/Purpose: Treat to target in rheumatoid arthritis (RA) suggests escalation of therapy in patients whose scores are high or moderate on a disease activity index…
  • Abstract Number: 0326 • ACR Convergence 2023

    Assessment of Depression in Ankylosing Spondylitis Using Center for Epidemiologic Studies Depression Scale

    Yvette Farran1, Mark Hwang1, John Reveille2, Lianne Gensler3, Accelerating Medicines Partnership Program RA SLE Network4, Mariko Ishimori4 and Michael Ward5, 1The University of Texas Health Science Center at Houston McGovern Medical School, Houston, TX, 2The University of Texas Health Science Center, Houston, TX, 3University of California San Francisco, Department of Medicine, Division of Rheumatology, San Francisco, CA, 4Cedars-Sinai Medical Center, Los Angeles, CA, 5National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, US Department of Health and Human Services, Bethesda, MD

    Background/Purpose: Ankylosing Spondylitis (AS) is a chronic inflammatory disease that primarily affects the spine and sacroiliac joints. Depression is a common comorbidity in AS patients…
  • Abstract Number: 1924 • ACR Convergence 2023

    Impact of the COVID-19 Pandemic on Clinical and Psychosocial Features of Patients with UCTD

    Caroline Siegel1, Lucy Masto1, Amaya Smole1, Bessie Stamm1, JoAnn Vega1, Dongmei Sun1, Deanna Jannat-Khah1, Michael Lockshin2, Lisa Sammaritano2 and Medha Barbhaiya2, 1Hospital for Special Surgery, New York, NY, 2Hospital for Special Surgery, Weill Cornell Medicine, New York, NY

    Background/Purpose: The early COVID-19 pandemic led to physical and psychological burdens for patients with systemic rheumatic diseases, whether or not they had had COVID-19. To…
  • Abstract Number: 0329 • ACR Convergence 2023

    Factors Associated with Suicidal Ideation Among Patients with Inflammatory Rheumatic Musculoskeletal Disease: A Case-Control Study

    Eike von Schlichting1, Jan Dieris-Hirche2, Imke Redeker3, Xenofon Baraliakos4 and Uta Kiltz5, 1Ruhr-Universität Bochum and Rheumazentrum Ruhrgebiet, Herne, Germany, 2LWL-University Hospital, Department of Psychosomatic Medicine and Psychotherapy, Ruhr Universität Bochum, Bochum, Germany, 3Ruhr Universität Bochum, Bochum, Germany, 4Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Herne, Germany, 5Rheumazentrum Ruhrgebiet, Herne, Germany

    Background/Purpose: Mental health contributes to the morbidity of patients with inflammatory rheumatic musculoskeletal disease (iRMD). Despite extensive research conducted on the prevalence of depressive disorders,…
  • Abstract Number: 1985 • ACR Convergence 2023

    Preliminary Results for the Total Knee Replacement Coaching Program for Patients Preparing to Undergo Total Knee Arthroplasty, a Pilot Randomized Trial

    Noelia Hernandez1, Yuliana Dominguez Paez2, Assem Jabri2, Mackenzie Brown2, Geyanne Lui3, Wai-Kwong Hui4, Michael Parks4, Alejandro Gonzalez Della Valle4, Fred Cushner4, Peter Sculco4, Thomas Sculco4, Mathias Bostrom4, Alejandro Leali4, Jason Blevins4, Jose Rodriguez4, Gwo-Chin Lee4, Lisa Mandl5, Susan Goodman4, Samprit Banerjee2, Monika Safford6 and Iris Navarro-Millán7, 1Weill Cornell Medicine, The Bronx, NY, 2Weill Cornell Medicine, New York, NY, 3New York Institute of Technology, New York, NY, 4Hospital for Special Surgery, New York, NY, 5Hospital for Special Surgery, Weill Cornell Medicine, New York, NY, 6WCM Department of Medicine, New York, NY, 7Weill Cornell Medicine, Hospital for Special Surgery, New York, NY

    Background/Purpose: Up to 30% of patients with primary knee osteoarthritis (KOA) who have undergone Total Knee Replacement (TKR) continue to experience knee pain after surgery.High…
  • Abstract Number: 0672 • ACR Convergence 2023

    Risk of New-onset Depression in Patients with Systemic Sclerosis : A Nationwide Population-based Study

    Hahee Son and Su-Jin Moon, Yeouido St. Mary's Hospital, Catholic University of Korea, Seoul, South Korea

    Background/Purpose: Systemic sclerosis (SSc) is a rare chronic inflammatory disease characterized by vasculopathy, autoimmunity and progressive fibrosis in various organs. The patients with SSc are…
  • Abstract Number: 2037 • ACR Convergence 2023

    Assessing Risk of Depression in Common Rheumatologic Disorders Using Diagnostic Codes, Survey Scores, and Propensity Score Matching Methodology

    COMFORT ANIM-KORANTENG1, YONG EUN2, Okeoghene Akpoigbe2 and AMANDA SAMMUT2, 1Harlem Hospital Center, New York, NY, 2NYCHH- HARLEM, New York, NY

    Background/Purpose: Many studies have shown that rheumatologic conditions are associated with a higher risk of depression. The two most common methods to detect depression in…
  • Abstract Number: 006 • 2023 Pediatric Rheumatology Symposium

    Implementation of Automated Depression Screening in Patients with Lupus in a Tertiary Pediatric Rheumatology Clinic

    Lauren Harper1, Alana Goldstein-Leever1, James Gallup1, Vidya Sivaraman2, Stacy Ardoin1, Kyla Driest1, Evan Mulvhihill3 and Alysha Taxter4, 1Nationwide Children's Hospital, Columbus, OH, 2Nationwide Children's Hospital/ The Ohio State University, Columbus, OH, 3Nemours Children's Hospital, 4Nationwide Children's Hospital, Columbus, OH

    Background/Purpose: Patients with chronic rheumatic conditions, particularly lupus, have higher rates of depression, which significantly impacts their lives and can lead to poor medication compliance…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology